Hoshi Iryosanki Co., Ltd. (7634) AI Stock Analysis

Hoshi Iryosanki Co., Ltd.

(TSE/TYO:7634)

Select Model

Rating:76Outperform

Price Target:JPY 5,797.00▲(17.95% Upside)

Action:reiterated

Date:08/17/26

The score is driven primarily by solid financial performance—especially the low-leverage balance sheet and steady operating profitability—plus supportive valuation (low P/E and a dividend). Technical indicators are mixed, with longer-term trend support but near-term softness and weak stochastic momentum, which tempers the overall rating.

Positive Factors

Steady Revenue and Operating ProfitabilityThe company has expanded its revenue base while preserving solid operating profitability. This combination indicates an established distribution franchise and suggests that its healthcare-provider relationships can support durable earnings over the next several quarters.

Negative Factors

Moderate Revenue Growth PaceAlthough revenue has grown over time, the reported growth rate is modest. A slower expansion pace may limit operating leverage and make future earnings increasingly dependent on margin management, product mix, or gains in the domestic healthcare market.

Hoshi Iryosanki Co., Ltd. (7634) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 15.55B
Dividend Yield: 1.81%
Average Volume (3M): 544
Price to Earnings (P/E): 11.2
Beta (1Y): 0.05
Revenue Growth: 2.05%
EPS Growth: -8.63%
Country: Japan
Employees: 527
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Hoshi Iryosanki Co., Ltd. Business Overview & Revenue Model

Company Description

Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare,...

How the Company Makes Money

The company primarily makes money by selling and distributing medical devices and healthcare-related products to medical institutions in Japan. Revenue is generated mainly from (1) product sales (i.e., wholesaling/distribution margins earned between...

Hoshi Iryosanki Co., Ltd. Financial Statement Overview

Summary

Strong financial foundation with steady revenue growth and stable operating margins, supported by a conservatively financed balance sheet (very low leverage and rising equity). Offsetting this, net profitability and ROE softened in 2026 versus 2025, and free cash flow has shown some year-to-year volatility.

Income Statement

78Positive

Balance Sheet

90Very Positive

Cash Flow

74Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	15.56B	15.52B	15.10B	14.78B	13.78B	12.77B
Gross Profit	7.70B	7.39B	7.31B	6.96B	6.51B	6.03B
EBITDA	2.97B	2.87B	2.81B	2.86B	2.71B	2.48B
Net Income	1.39B	1.37B	1.46B	1.40B	1.25B	1.11B
Balance Sheet
Total Assets	26.53B	26.74B	24.59B	23.04B	21.25B	20.25B
Cash, Cash Equivalents and Short-Term Investments	11.27B	11.21B	10.63B	9.76B	9.03B	8.76B
Total Debt	946.35M	1.28B	1.09B	834.44M	1.00B	1.29B
Total Liabilities	6.09B	6.42B	5.87B	5.66B	5.66B	5.74B
Stockholders Equity	20.13B	20.01B	18.43B	17.10B	15.37B	14.29B
Cash Flow
Free Cash Flow	0	2.16B	1.65B	2.15B	1.89B	1.40B
Operating Cash Flow	0	2.48B	2.19B	2.40B	2.29B	1.97B
Investing Cash Flow	0	-1.54B	-5.28B	-744.85M	-1.06B	-690.26M
Financing Cash Flow	0	-948.38M	-739.64M	-902.90M	-957.69M	-936.90M

Hoshi Iryosanki Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price4915.00

Price Trends

50DMA5114.31Negative

100DMA5040.20Negative

200DMA5071.97Negative

Market Momentum

MACD-43.60Positive

RSI40.36Neutral

STOCH9.05Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7634, the sentiment is Negative. The current price of 4915.00 is below the 20-day moving average (MA) of 5020.25, below the 50-day MA of 5114.31, and below the 200-day MA of 5071.97, indicating a bearish trend. The MACD of -43.60 indicates Positive momentum. The RSI at 40.36 is Neutral, neither overbought nor oversold. The STOCH value of 9.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7634.

Hoshi Iryosanki Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:7634 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:6678	82Outperform	JPY 18.42B	12.22	―	5.97%	20.88%	44.61%
JP:7634	76Outperform	JPY 15.37B	11.17	―	1.81%	2.05%	-8.63%
JP:7707	61Neutral	JPY 5.59B	14.02	―	0.99%	11.17%	―
JP:4350	57Neutral	JPY 16.87B	18.82	―	2.15%	8.19%	-25.81%
JP:7743	54Neutral	JPY 23.76B	21.80	―	1.91%	2.22%	-2.17%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:7600	47Neutral	JPY 15.22B	-69.06	―	2.94%	-6.64%	67.08%

* Healthcare Sector Average

Performance Comparison

JP:7634 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:7634	Hoshi Iryosanki Co., Ltd.	4975.00	257.93	5.47%
JP:4350	Medical System Network Co., Ltd.	559.00	72.13	14.82%
JP:6678	Techno Medica Co., Ltd.	2161.00	334.37	18.31%
JP:7600	Japan Medical Dynamic Marketing, Inc.	578.00	98.50	20.54%
JP:7707	Precision System Science Co.,Ltd	202.00	17.00	9.19%
JP:7743	Seed Co., Ltd.	785.00	228.68	41.11%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026

Hoshi Iryosanki Co., Ltd. AI Stock Analysis